G protein-coupled receptors (GPCRs) are involved in many important physiological processes and are the targets of many drugs. They detect extracellular signals and activate intracellular effector proteins, usually via heterotrimeric G proteins. When a ligand binds to a GPCR, it causes a conformational change that allows the G protein's α subunit to exchange GDP for GTP. The GTP-bound α subunit then dissociates from the βγ complex and activates downstream effectors such as adenylyl cyclase. Eventually the Gα hydrolyzes GTP to GDP and reassociates with the βγ complex to terminate signaling. Rodbell and Gilman received the Nobel Prize for discovering GPCRs and their role in signal trans
G protein-coupled receptors (GPCRs) are a large family of transmembrane receptors that sense molecules outside the cell and activate intracellular signal transduction pathways. They have seven transmembrane domains and transmit signals by coupling to heterotrimeric G proteins on the inner cell surface. When an agonist binds to a GPCR, it causes a conformational change that activates the G protein, starting intracellular signaling cascades through second messengers like cAMP or IP3. Approximately half of all drugs target GPCRs, making them an important drug discovery area.
Receptor Effector coupling by G-Proteins Zarlish attique 187104 ZarlishAttique1
This document is a PowerPoint presentation by Zarlish Attique on the topic of receptor-effector coupling by G-proteins. It discusses how G-proteins transmit signals from stimuli outside a cell to its interior through conformational changes when ligands bind to G-protein coupled receptors. This causes the G-protein's alpha subunit to exchange GDP for GTP, dissociate from other subunits and bind to effector proteins like enzymes to transmit signals via second messengers. Common types of G-proteins include Gs, Gi, Go and Gq. The presentation provides details on the structure and function of G-protein coupled receptors and G-proteins, and gives adenyl cyclase as an example of the
G proteins act as molecular switches inside cells that transmit signals from stimuli outside the cell to its interior. They were discovered when researchers found that adrenaline receptors stimulate G proteins, which then stimulate enzymes inside the cell rather than the receptors stimulating enzymes directly. There are two classes of G proteins: monomeric small GTPases and heteromeric G protein complexes composed of α, β, and γ subunits. The G protein subclasses Gαs, Gαq, Gαi, and Gαt each activate or inhibit different intracellular signaling pathways.
This document discusses G-protein coupled receptors (GPCRs). It defines receptors and describes the main types, focusing on GPCRs. GPCRs signal through G-proteins that activate different intracellular pathways. The three major pathways are cAMP, PLC, and channel regulation. GPCRs are involved in many physiological processes and are targets for drugs to treat conditions like asthma, hypertension, schizophrenia and Parkinson's disease. Diseases can result from gene mutations or bacterial toxins affecting GPCRs. Research areas include orphan GPCRs and ligand-induced selective signaling. GPCRs have potential as therapeutic targets for type 2 diabetes.
G protien coupled receptor by yatendra singhYatendra Singh
This document discusses G protein-coupled receptors (GPCRs), which are a large family of cell membrane receptors linked to intracellular effector systems through G proteins. GPCRs have seven transmembrane domains and interact with a wide range of ligands like neurotransmitters, hormones, and light-sensitive compounds. They function by activating heterotrimeric G proteins composed of α, β, and γ subunits, which then activate various intracellular effector pathways like adenylyl cyclase and phospholipase C. GPCRs are important drug targets, comprising about 40% of modern medicines.
G protein-coupled receptors (GPCRs) are seven transmembrane receptors that activate intracellular signaling pathways through heterotrimeric G proteins. When an agonist binds to a GPCR, it causes a conformational change activating the G protein's α subunit. The activated α subunit then interacts with downstream effectors like adenylyl cyclase or phospholipase C. This leads to the production of second messengers like cAMP or IP3. Mutations in GPCRs and G proteins can cause disease by disrupting signaling, with loss or gain of function mutations associated with various endocrine disorders and cancers.
This document discusses G protein-coupled receptors (GPCRs). It notes that GPCRs constitute the largest gene family in the human genome, with over 900 genes, and are the target of 40-50% of prescription drugs. The structure of GPCRs is described, including an extracellular region, 7 transmembrane regions, and intracellular region. The roles of GPCRs in immunity signaling and as the receptor for the bacterial peptide fMLP are also mentioned. Major mammalian GPCR subfamilies include rhodopsin-like, glucagon-like, and metabotropic glutamate receptor families.
G protein-coupled receptors (GPCRs) are a large family of transmembrane receptors that sense molecules outside the cell and activate intracellular signal transduction pathways. They have seven transmembrane domains and transmit signals by coupling to heterotrimeric G proteins on the inner cell surface. When an agonist binds to a GPCR, it causes a conformational change that activates the G protein, starting intracellular signaling cascades through second messengers like cAMP or IP3. Approximately half of all drugs target GPCRs, making them an important drug discovery area.
Receptor Effector coupling by G-Proteins Zarlish attique 187104 ZarlishAttique1
This document is a PowerPoint presentation by Zarlish Attique on the topic of receptor-effector coupling by G-proteins. It discusses how G-proteins transmit signals from stimuli outside a cell to its interior through conformational changes when ligands bind to G-protein coupled receptors. This causes the G-protein's alpha subunit to exchange GDP for GTP, dissociate from other subunits and bind to effector proteins like enzymes to transmit signals via second messengers. Common types of G-proteins include Gs, Gi, Go and Gq. The presentation provides details on the structure and function of G-protein coupled receptors and G-proteins, and gives adenyl cyclase as an example of the
G proteins act as molecular switches inside cells that transmit signals from stimuli outside the cell to its interior. They were discovered when researchers found that adrenaline receptors stimulate G proteins, which then stimulate enzymes inside the cell rather than the receptors stimulating enzymes directly. There are two classes of G proteins: monomeric small GTPases and heteromeric G protein complexes composed of α, β, and γ subunits. The G protein subclasses Gαs, Gαq, Gαi, and Gαt each activate or inhibit different intracellular signaling pathways.
This document discusses G-protein coupled receptors (GPCRs). It defines receptors and describes the main types, focusing on GPCRs. GPCRs signal through G-proteins that activate different intracellular pathways. The three major pathways are cAMP, PLC, and channel regulation. GPCRs are involved in many physiological processes and are targets for drugs to treat conditions like asthma, hypertension, schizophrenia and Parkinson's disease. Diseases can result from gene mutations or bacterial toxins affecting GPCRs. Research areas include orphan GPCRs and ligand-induced selective signaling. GPCRs have potential as therapeutic targets for type 2 diabetes.
G protien coupled receptor by yatendra singhYatendra Singh
This document discusses G protein-coupled receptors (GPCRs), which are a large family of cell membrane receptors linked to intracellular effector systems through G proteins. GPCRs have seven transmembrane domains and interact with a wide range of ligands like neurotransmitters, hormones, and light-sensitive compounds. They function by activating heterotrimeric G proteins composed of α, β, and γ subunits, which then activate various intracellular effector pathways like adenylyl cyclase and phospholipase C. GPCRs are important drug targets, comprising about 40% of modern medicines.
G protein-coupled receptors (GPCRs) are seven transmembrane receptors that activate intracellular signaling pathways through heterotrimeric G proteins. When an agonist binds to a GPCR, it causes a conformational change activating the G protein's α subunit. The activated α subunit then interacts with downstream effectors like adenylyl cyclase or phospholipase C. This leads to the production of second messengers like cAMP or IP3. Mutations in GPCRs and G proteins can cause disease by disrupting signaling, with loss or gain of function mutations associated with various endocrine disorders and cancers.
This document discusses G protein-coupled receptors (GPCRs). It notes that GPCRs constitute the largest gene family in the human genome, with over 900 genes, and are the target of 40-50% of prescription drugs. The structure of GPCRs is described, including an extracellular region, 7 transmembrane regions, and intracellular region. The roles of GPCRs in immunity signaling and as the receptor for the bacterial peptide fMLP are also mentioned. Major mammalian GPCR subfamilies include rhodopsin-like, glucagon-like, and metabotropic glutamate receptor families.
G-protein coupled receptors (GPCRs) are the largest family of membrane receptors and the target of many drugs. They have seven transmembrane domains and signal through G proteins and second messengers like cAMP or IP3. Upon ligand binding, the GPCR activates a G protein that then activates or inhibits downstream effectors to produce a cellular response. GPCRs regulate many physiological functions and half of all drugs target these receptors. Recent research focuses on deorphaning orphan GPCRs and understanding how GPCR mutations can cause disease.
GPCRs are the most dynamic and most abundant all the receptors. The G protein-coupled receptor (GPCR) superfamily comprises the largest and most diverse group of proteins in mammals. GPCRs are responsible for every aspect of human biology from vision, taste, sense of smell, sympathetic and parasympathetic nervous functions, metabolism, and immune regulation to reproduction. GPCRs interact with a number of ligands ranging from photons, ions, amino acids, odorants, pheromones, eicosanoids, neurotransmitters, peptides, proteins, and hormones.
Nevertheless, for the majority of GPCRs, the identity of their natural ligands is still unknown, hence remain orphan receptors.
The simple dogma that underpins much of our current understanding of GPCRs, namely,
one GPCR gene− one GPCR protein− one functional GPCR− one G protein −one response
is showing distinct signs of wear.
G Protein Coupled Receptors (GPCRs) and CancerDayananda Salam
GPCRs play an important role in many types of cancer through their activation by various ligands. Some key points:
- GPCRs make up over 1% of the human genome and are the target of over 50% of drugs. They signal through G proteins and regulate many important cellular functions.
- In cancer, GPCRs activated by ligands like LPA, SDF1, chemokines promote processes like growth, migration, angiogenesis and metastasis. Examples include LPA1 in breast cancer and CXCR4 in ovarian cancer.
- GPCRs can also interact with other pathways like EGFR to enhance signaling. Orphan GPCRs without known ligands may play emerging roles in cancers like GPR49
This presentation is about the functioning of G-Protein coupled receptors. It also gives necessary information about the G-protein and it functions. It ends by explaining some of the faults associated with GPCR (G-PROTEIN COUPLED RECEPTORS).
Cellular communication (signal transduction)Hara O.
Cellular communication relies on signal transduction pathways where signaling molecules bind to receptors to transmit information between cells. This involves three main steps: 1) A signaling molecule or ligand binds to a receptor on the target cell. 2) This triggers a series of intracellular events, often involving secondary messengers and protein kinases, that amplify the signal. 3) The signal is translated into a specific cellular response such as metabolism, proliferation, or gene expression changes. Key components of these pathways include G-protein coupled receptors, receptor tyrosine kinases, ion channels, and intracellular signaling proteins. Together, these pathways allow cells to coordinate complex behaviors through intercellular communication networks.
Robert J. Lefkowitz and Brian K. Kobilka won the 2012 Nobel Prize in Chemistry for their groundbreaking work studying G-protein–coupled receptors (GPCRs). Their research revealed key insights into how GPCRs function at the molecular level to transmit signals from outside to inside of cells. Specifically, Lefkowitz and Kobilka were able to clone and sequence the first GPCR, detect their binding properties, determine their three-dimensional structure, and elucidate the allosteric mechanism of signal transduction, establishing GPCRs as a family of related receptors. Their seminal findings provided a deeper understanding of the intricate signaling mechanisms of GPCRs and laid the foundation for advancing research and drug development targeting
This document discusses the mechanisms of hormone and neurotransmitter action in the body. It describes the different types of receptors, including membrane receptors and intracellular receptors. It also explains the various signal transduction pathways triggered by receptors, such as G protein-coupled receptors that activate adenylate cyclase or phospholipase C, receptors with intrinsic enzymatic activity like guanylate cyclase, and receptors with tyrosine kinase activity like the insulin receptor. The key second messengers produced by these pathways, like cAMP, Ca2+, cGMP, and phosphorylated proteins, are also outlined.
1. INTRODUCTION
2. WHAT IS A RECEPTOR
3. HISTORY
4. CONCEPT OF CELL SIGNALLING
5. RECEPTOR SUPER FAMILIES
6. GPCRs- SIGNAL TRANSDUCTION & ITS SECOND MESSENGERS
Market research report on G-Protein Coupled Receptors (GPCR) covers the types of GPCR Families and the various ligands targeting GPCR. The GPCR families covered include Rhodopsin, Secretin, Metabotropic glutamate and Other. The Ligands targeting GPCRs include Peptides or Proteins, Biogenic Amines, Lipids and Other. The report provides market analysis of each of the Families and ligands targeting GPCRs by their respective categories. The study includes estimations and predictions for the total global GPCR Drug targets market and also key regional markets that include North America, Europe, Asia-Pacific and Rest of World. Estimations and predictions (2005-2020) are illustrated graphically with 35 exhibits. Business profiles of 10+ major companies engaged in developing GPCR targeted drugs, GPCR cell lines and GPCR Assays are discussed in the report. The report serves as a guide to global GPCR ?Drug Targets industry, covering more than 100 companies that are engaged in the development of GPCR Targeted Drugs, GPCR Assays Information related to recent product releases, Assay developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report. Compilation of Worldwide Patents and Research related to GPCR Drug Targets is also provided.
The document discusses G-protein coupled receptors (GPCRs), which comprise the largest group of proteins in mammals. GPCRs have 7 transmembrane domains and signal from outside the cell to the interior by coupling to G proteins. They are involved in many human biological processes and about 45% of pharmaceutical drugs target GPCRs. GPCRs activate different intracellular signaling pathways upon ligand binding, including the cAMP pathway, IP3-DAG pathway, and channel regulation pathways, mediated by different G protein subunits.
GPCR dimers are ubiquitous in nature and mediate many physiological processes. While evidence suggests most GPCRs function as dimers, criticism remains that not all receptors dimerize under physiological conditions. Techniques like co-immunoprecipitation, FRET, and BRET are used to study dimers, but overexpression models may produce non-physiological dimers. Research now focuses on identifying physiologically relevant dimers expressed together in native cell types. The drug development paradigm is also shifting from single molecular targets to pathway-based models using in vivo screening of primary cell cultures and stem cells to better represent human biology.
General principles of signal transduction
G Protein-coupled Receptors (GPCRs): Structure and Mechanism.
GPCRs that Regulate Adenylyl Cyclase.
GPCRs that Activate Phospholipase C.
GPCRs that Regulate Ion Channels.
GPCRs that Regulate Gene Transcription.
Functional Analysis Of Heterologous Gpcr Signaling Pathways In Yeastbeneshjoseph
The document discusses using yeast as a model system to study heterologous G protein-coupled receptors (GPCRs). Yeast have signaling pathways that can be exploited to study GPCRs. Chimeric Gα proteins were developed to efficiently couple yeast and mammalian GPCRs. Methods like modifying receptor sequences or co-expressing receptor activity modifying proteins allow functional expression of GPCRs in yeast. This enables large-scale screens that can define receptor-G protein specificity and identify novel ligands, improving drug discovery. Studies in yeast have characterized receptors, G proteins, and their regulators like receptor kinases and RGS proteins. Both Saccharomyces cerevisiae and Schizosaccharomyces pombe yeast are discussed
G-protein coupled receptors (GPCRs) are the largest family of cell surface receptors. Upon ligand binding, GPCRs activate intracellular G proteins that propagate signals via second messenger molecules. There are three major families of G proteins - Gs stimulates adenylate cyclase and increases cAMP, Gi inhibits adenylate cyclase and decreases cAMP, and Gq activates phospholipase C and increases intracellular calcium. Receptor tyrosine kinases (RTKs) activate intracellular signaling pathways through autophosphorylation upon ligand binding, which recruits signaling proteins containing SH2 domains. Major RTK pathways include Ras-MAPK, which regulates cell growth and proliferation.
This document provides an overview of cellular signal transduction. It defines signal transduction as the process by which a chemical or physical signal is transmitted through a cell via a series of molecular events, mostly protein phosphorylation by protein kinases, resulting in a cellular response. It classifies signal transduction pathways based on their initiation by lipid-soluble or water-soluble messengers and describes the major components involved, including receptors, G proteins, second messengers, and protein kinases. Specific examples of signal transduction pathways mediated by G protein-coupled receptors, receptor tyrosine kinases, and ligand-gated ion channels are discussed.
This document discusses orphan G protein-coupled receptors (GPCRs) and efforts to identify endogenous ligands for these receptors. It provides background on the IUPHAR database and criteria for designating pairings between orphan receptors and endogenous ligands. 57 class A, 28 class B, and 6 class C orphan GPCRs currently have no reported pairings. The document calls for further research to validate reported pairings and identify ligands for the remaining orphan GPCRs to advance our understanding of their functions and therapeutic potential.
Dr. Pavani discusses G protein-coupled receptors (GPCRs), which are integral membrane proteins that sense molecules outside the cell and activate internal signal transduction pathways and cellular responses. There are over 800 GPCRs in humans that detect a wide range of ligands and are involved in many physiological processes. GPCRs work by coupling to G proteins, which activate various intracellular effectors like adenylyl cyclase, phospholipase C, and ion channels. Dysregulation of GPCR signaling can lead to many human diseases. Martin Rodbell and Alfred Gilman were awarded the 1994 Nobel Prize in Physiology or Medicine for their discoveries related to G proteins and GPCR signal transduction.
This document discusses cellular signalling and molecular mechanisms of drug action. It describes the different types of cell signalling including extracellular signals like hormones and intracellular signals like calcium and cyclic nucleotides. It also explains different receptor types like G-protein coupled receptors and ligand-gated ion channels. Additionally, it covers molecular mechanisms of drug action like receptor occupancy models and transducer mechanisms. Finally, it discusses ion channels involved in cellular signalling like sodium, calcium and potassium channels as well as their pharmacological modulation.
This document summarizes 5 major categories of transducer mechanisms:
1) G-protein coupled receptors which activate downstream effectors like adenylyl cyclase or phospholipase C.
2) Ion channel receptors which directly open or close ion channels.
3) Transmembrane enzyme-linked receptors which activate intracellular protein kinases.
4) Transmembrane JAK-STAT binding receptors which activate the JAK/STAT signaling pathway.
5) Receptors regulating gene expression which bind intracellularly to directly regulate gene transcription.
G protein-coupled receptors (GPCRs) are a large family of transmembrane receptors that sense molecules outside the cell and activate intracellular signal transduction pathways. They have seven transmembrane domains and transmit signals by coupling to heterotrimeric G proteins on the inner cell surface. When an agonist binds to a GPCR, it causes a conformational change that activates the G protein, starting intracellular signaling cascades through second messengers like cAMP or IP3. Approximately half of all drugs target GPCRs, making them an important drug discovery area.
G-protein coupled receptors (GPCRs) are the largest family of membrane receptors and the target of many drugs. They have seven transmembrane domains and signal through G proteins and second messengers like cAMP or IP3. Upon ligand binding, the GPCR activates a G protein that then activates or inhibits downstream effectors to produce a cellular response. GPCRs regulate many physiological functions and half of all drugs target these receptors. Recent research focuses on deorphaning orphan GPCRs and understanding how GPCR mutations can cause disease.
GPCRs are the most dynamic and most abundant all the receptors. The G protein-coupled receptor (GPCR) superfamily comprises the largest and most diverse group of proteins in mammals. GPCRs are responsible for every aspect of human biology from vision, taste, sense of smell, sympathetic and parasympathetic nervous functions, metabolism, and immune regulation to reproduction. GPCRs interact with a number of ligands ranging from photons, ions, amino acids, odorants, pheromones, eicosanoids, neurotransmitters, peptides, proteins, and hormones.
Nevertheless, for the majority of GPCRs, the identity of their natural ligands is still unknown, hence remain orphan receptors.
The simple dogma that underpins much of our current understanding of GPCRs, namely,
one GPCR gene− one GPCR protein− one functional GPCR− one G protein −one response
is showing distinct signs of wear.
G Protein Coupled Receptors (GPCRs) and CancerDayananda Salam
GPCRs play an important role in many types of cancer through their activation by various ligands. Some key points:
- GPCRs make up over 1% of the human genome and are the target of over 50% of drugs. They signal through G proteins and regulate many important cellular functions.
- In cancer, GPCRs activated by ligands like LPA, SDF1, chemokines promote processes like growth, migration, angiogenesis and metastasis. Examples include LPA1 in breast cancer and CXCR4 in ovarian cancer.
- GPCRs can also interact with other pathways like EGFR to enhance signaling. Orphan GPCRs without known ligands may play emerging roles in cancers like GPR49
This presentation is about the functioning of G-Protein coupled receptors. It also gives necessary information about the G-protein and it functions. It ends by explaining some of the faults associated with GPCR (G-PROTEIN COUPLED RECEPTORS).
Cellular communication (signal transduction)Hara O.
Cellular communication relies on signal transduction pathways where signaling molecules bind to receptors to transmit information between cells. This involves three main steps: 1) A signaling molecule or ligand binds to a receptor on the target cell. 2) This triggers a series of intracellular events, often involving secondary messengers and protein kinases, that amplify the signal. 3) The signal is translated into a specific cellular response such as metabolism, proliferation, or gene expression changes. Key components of these pathways include G-protein coupled receptors, receptor tyrosine kinases, ion channels, and intracellular signaling proteins. Together, these pathways allow cells to coordinate complex behaviors through intercellular communication networks.
Robert J. Lefkowitz and Brian K. Kobilka won the 2012 Nobel Prize in Chemistry for their groundbreaking work studying G-protein–coupled receptors (GPCRs). Their research revealed key insights into how GPCRs function at the molecular level to transmit signals from outside to inside of cells. Specifically, Lefkowitz and Kobilka were able to clone and sequence the first GPCR, detect their binding properties, determine their three-dimensional structure, and elucidate the allosteric mechanism of signal transduction, establishing GPCRs as a family of related receptors. Their seminal findings provided a deeper understanding of the intricate signaling mechanisms of GPCRs and laid the foundation for advancing research and drug development targeting
This document discusses the mechanisms of hormone and neurotransmitter action in the body. It describes the different types of receptors, including membrane receptors and intracellular receptors. It also explains the various signal transduction pathways triggered by receptors, such as G protein-coupled receptors that activate adenylate cyclase or phospholipase C, receptors with intrinsic enzymatic activity like guanylate cyclase, and receptors with tyrosine kinase activity like the insulin receptor. The key second messengers produced by these pathways, like cAMP, Ca2+, cGMP, and phosphorylated proteins, are also outlined.
1. INTRODUCTION
2. WHAT IS A RECEPTOR
3. HISTORY
4. CONCEPT OF CELL SIGNALLING
5. RECEPTOR SUPER FAMILIES
6. GPCRs- SIGNAL TRANSDUCTION & ITS SECOND MESSENGERS
Market research report on G-Protein Coupled Receptors (GPCR) covers the types of GPCR Families and the various ligands targeting GPCR. The GPCR families covered include Rhodopsin, Secretin, Metabotropic glutamate and Other. The Ligands targeting GPCRs include Peptides or Proteins, Biogenic Amines, Lipids and Other. The report provides market analysis of each of the Families and ligands targeting GPCRs by their respective categories. The study includes estimations and predictions for the total global GPCR Drug targets market and also key regional markets that include North America, Europe, Asia-Pacific and Rest of World. Estimations and predictions (2005-2020) are illustrated graphically with 35 exhibits. Business profiles of 10+ major companies engaged in developing GPCR targeted drugs, GPCR cell lines and GPCR Assays are discussed in the report. The report serves as a guide to global GPCR ?Drug Targets industry, covering more than 100 companies that are engaged in the development of GPCR Targeted Drugs, GPCR Assays Information related to recent product releases, Assay developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report. Compilation of Worldwide Patents and Research related to GPCR Drug Targets is also provided.
The document discusses G-protein coupled receptors (GPCRs), which comprise the largest group of proteins in mammals. GPCRs have 7 transmembrane domains and signal from outside the cell to the interior by coupling to G proteins. They are involved in many human biological processes and about 45% of pharmaceutical drugs target GPCRs. GPCRs activate different intracellular signaling pathways upon ligand binding, including the cAMP pathway, IP3-DAG pathway, and channel regulation pathways, mediated by different G protein subunits.
GPCR dimers are ubiquitous in nature and mediate many physiological processes. While evidence suggests most GPCRs function as dimers, criticism remains that not all receptors dimerize under physiological conditions. Techniques like co-immunoprecipitation, FRET, and BRET are used to study dimers, but overexpression models may produce non-physiological dimers. Research now focuses on identifying physiologically relevant dimers expressed together in native cell types. The drug development paradigm is also shifting from single molecular targets to pathway-based models using in vivo screening of primary cell cultures and stem cells to better represent human biology.
General principles of signal transduction
G Protein-coupled Receptors (GPCRs): Structure and Mechanism.
GPCRs that Regulate Adenylyl Cyclase.
GPCRs that Activate Phospholipase C.
GPCRs that Regulate Ion Channels.
GPCRs that Regulate Gene Transcription.
Functional Analysis Of Heterologous Gpcr Signaling Pathways In Yeastbeneshjoseph
The document discusses using yeast as a model system to study heterologous G protein-coupled receptors (GPCRs). Yeast have signaling pathways that can be exploited to study GPCRs. Chimeric Gα proteins were developed to efficiently couple yeast and mammalian GPCRs. Methods like modifying receptor sequences or co-expressing receptor activity modifying proteins allow functional expression of GPCRs in yeast. This enables large-scale screens that can define receptor-G protein specificity and identify novel ligands, improving drug discovery. Studies in yeast have characterized receptors, G proteins, and their regulators like receptor kinases and RGS proteins. Both Saccharomyces cerevisiae and Schizosaccharomyces pombe yeast are discussed
G-protein coupled receptors (GPCRs) are the largest family of cell surface receptors. Upon ligand binding, GPCRs activate intracellular G proteins that propagate signals via second messenger molecules. There are three major families of G proteins - Gs stimulates adenylate cyclase and increases cAMP, Gi inhibits adenylate cyclase and decreases cAMP, and Gq activates phospholipase C and increases intracellular calcium. Receptor tyrosine kinases (RTKs) activate intracellular signaling pathways through autophosphorylation upon ligand binding, which recruits signaling proteins containing SH2 domains. Major RTK pathways include Ras-MAPK, which regulates cell growth and proliferation.
This document provides an overview of cellular signal transduction. It defines signal transduction as the process by which a chemical or physical signal is transmitted through a cell via a series of molecular events, mostly protein phosphorylation by protein kinases, resulting in a cellular response. It classifies signal transduction pathways based on their initiation by lipid-soluble or water-soluble messengers and describes the major components involved, including receptors, G proteins, second messengers, and protein kinases. Specific examples of signal transduction pathways mediated by G protein-coupled receptors, receptor tyrosine kinases, and ligand-gated ion channels are discussed.
This document discusses orphan G protein-coupled receptors (GPCRs) and efforts to identify endogenous ligands for these receptors. It provides background on the IUPHAR database and criteria for designating pairings between orphan receptors and endogenous ligands. 57 class A, 28 class B, and 6 class C orphan GPCRs currently have no reported pairings. The document calls for further research to validate reported pairings and identify ligands for the remaining orphan GPCRs to advance our understanding of their functions and therapeutic potential.
Dr. Pavani discusses G protein-coupled receptors (GPCRs), which are integral membrane proteins that sense molecules outside the cell and activate internal signal transduction pathways and cellular responses. There are over 800 GPCRs in humans that detect a wide range of ligands and are involved in many physiological processes. GPCRs work by coupling to G proteins, which activate various intracellular effectors like adenylyl cyclase, phospholipase C, and ion channels. Dysregulation of GPCR signaling can lead to many human diseases. Martin Rodbell and Alfred Gilman were awarded the 1994 Nobel Prize in Physiology or Medicine for their discoveries related to G proteins and GPCR signal transduction.
This document discusses cellular signalling and molecular mechanisms of drug action. It describes the different types of cell signalling including extracellular signals like hormones and intracellular signals like calcium and cyclic nucleotides. It also explains different receptor types like G-protein coupled receptors and ligand-gated ion channels. Additionally, it covers molecular mechanisms of drug action like receptor occupancy models and transducer mechanisms. Finally, it discusses ion channels involved in cellular signalling like sodium, calcium and potassium channels as well as their pharmacological modulation.
This document summarizes 5 major categories of transducer mechanisms:
1) G-protein coupled receptors which activate downstream effectors like adenylyl cyclase or phospholipase C.
2) Ion channel receptors which directly open or close ion channels.
3) Transmembrane enzyme-linked receptors which activate intracellular protein kinases.
4) Transmembrane JAK-STAT binding receptors which activate the JAK/STAT signaling pathway.
5) Receptors regulating gene expression which bind intracellularly to directly regulate gene transcription.
G protein-coupled receptors (GPCRs) are a large family of transmembrane receptors that sense molecules outside the cell and activate intracellular signal transduction pathways. They have seven transmembrane domains and transmit signals by coupling to heterotrimeric G proteins on the inner cell surface. When an agonist binds to a GPCR, it causes a conformational change that activates the G protein, starting intracellular signaling cascades through second messengers like cAMP or IP3. Approximately half of all drugs target GPCRs, making them an important drug discovery area.
G-protein coupled receptors (GPCRs) are the largest family of membrane receptors that sense molecules outside the cell and activate intracellular signal transduction pathways. They have seven transmembrane domains and work by coupling to intracellular G proteins. When an agonist binds to a GPCR, it causes a conformational change that activates the G protein, starting intracellular signaling cascades like the cAMP or PLC pathways. These pathways control many cellular functions and make GPCRs the targets of about half of all drugs.
Cellular signal transduction involves signaling molecules activating receptors on target cells to initiate intracellular responses. There are various types of signaling molecules including proteins/peptides, amino acid/fatty acid derivatives, and steroids. These molecules bind to membrane receptors and induce intracellular second messengers like cAMP, IP3, Ca2+ that activate pathways culminating in altered gene expression, metabolism, or other biological effects. The document provides details on different receptor types, intracellular signaling pathways, and examples of signaling molecules that activate them.
This document discusses drug receptors and their role in mediating drug action. It describes the four main types of receptors: ligand-gated ion channels, G-protein coupled receptors, enzyme-linked receptors, and nuclear receptors. Ligand-gated ion channels directly open ion channels, while G-protein coupled receptors signal through G-proteins. Enzyme-linked receptors have intracellular enzyme domains, and nuclear receptors enter the nucleus to regulate gene transcription. Understanding receptors is important for rational drug design and determining mechanisms of drug action and selectivity.
This document provides information about a receptor pharmacology course taught by Professor Dr. Md. Shah Amran at the University of Dhaka. It was prepared by 5 students and contains contents on different types of receptors including ligand gated ion channels, G-protein coupled receptors, enzyme linked receptors, nuclear receptors, and a comparison of receptor types. Receptors are important macromolecules that bind drugs and mediate their effects in the body.
This document provides information about a receptor pharmacology course taught by Professor Dr. Md. Shah Amran at the University of Dhaka. It was prepared by 5 students and contains an introduction to receptors, classifications of different receptor types including ligand gated ion channels, G-protein coupled receptors, enzyme linked receptors, and nuclear receptors. It also discusses receptor-drug interactions, affinity, intrinsic activity, and mechanisms of cell surface and intracellular receptors.
Lecture 7 from a college level neuropharmacology course taught in the spring 2012 semester by Brian J. Piper, Ph.D. (psy391@gmail.com) at Willamette University.
G protein-coupled receptors (GPCRs) are integral membrane proteins that detect extracellular molecules and signal intracellular pathways. They have seven transmembrane domains and interact with G proteins. There are two principal signaling pathways: 1) the cAMP pathway, where the G protein activates adenylyl cyclase to produce cAMP, which activates protein kinase A and regulates genes and secretion; and 2) the phosphatidylinositol pathway, where the G protein activates phospholipase C to produce IP3 and DAG, which trigger calcium release and activate protein kinase C to phosphorylate target proteins and induce cellular responses. These pathways are connected by calcium-calmodulin, which regulates enzymes in both routes.
The document discusses second messenger systems. It describes how second messengers relay signals from cell surface receptors to target molecules inside the cell. Some key points discussed include:
- Earl Sutherland discovered cyclic AMP (cAMP) as the second messenger for epinephrine and won the Nobel Prize for this work.
- Common second messenger systems include those using cAMP, cGMP, phosphatidylinositol, and tyrosine kinases as secondary messengers.
- G proteins act as transducers between receptors and effectors and are important drug targets.
- cAMP and cGMP have several downstream targets including protein kinases that phosphorylate other proteins and regulate various cellular processes.
This document discusses the different types of receptors:
1) Ligand-gated ion channels directly open ion channels in response to neurotransmitters.
2) G-protein coupled receptors activate intracellular second messenger systems through G-proteins.
3) Kinase-linked receptors activate intracellular protein kinases.
4) Nuclear receptors regulate gene transcription by binding to DNA response elements as dimers.
This document summarizes G protein-coupled receptors (GPCRs) and ligand-gated ion channels. It notes that GPCRs are the largest family of receptors, with seven transmembrane domains that activate G proteins to trigger intracellular signaling pathways. Ligand-gated ion channels directly form ion channels when activated by neurotransmitters like acetylcholine and GABA. Second messengers downstream of GPCR signaling like cAMP and phosphoinositides are also discussed.
G protein coupled receptor and pharmacotherapeuticspriyanka527
This document provides an overview of G-protein coupled receptors (GPCRs) and their role in cell signaling. It discusses the history and structure of GPCRs, how they interact with G-proteins and secondary messengers like cAMP and IP3 to activate intracellular signaling pathways. These pathways regulate key cellular processes and are targets for drug development to treat diseases. The document also categorizes different classes of GPCRs and summarizes the mechanisms and physiological roles of various secondary messenger systems like cAMP, IP3, and ion channels in signal transduction.
G-protein coupled receptors (GPCRs) are the largest family of membrane receptors found in humans. They have seven transmembrane domains and are activated by extracellular ligands binding, which causes a conformational change and activation of an intracellular G protein. This leads to second messenger signaling pathways involving cAMP or phosphatidylinositol. GPCRs regulate many physiological processes and are involved in behaviors, moods, and cellular responses. Their activity is modulated by phosphorylation, arrestins, and degradation of second messengers.
- There are 4 main types of receptors: ligand-gated ion channels, G-protein coupled receptors, kinase-linked receptors, and nuclear receptors.
- Ligand-gated ion channels directly open ion channels, G-protein receptors signal through G-proteins, kinase receptors signal through phosphorylation, and nuclear receptors regulate gene transcription as transcription factors.
- Receptors recognize a wide range of ligands and allow cells to respond to changes in their internal or external environment through second messenger signaling pathways.
This document discusses pharmacodynamics, which is the study of how drugs act on the body and produce their effects. It describes several key concepts:
1. Drugs act by interacting with receptors or enzymes in tissues. Common sites of action include receptors, ion channels, and enzymes.
2. The mechanism of action describes how a drug modifies physiological or biochemical functions at the molecular level, such as by activating or inhibiting receptors.
3. Pharmacological effects refer to the physiological or biochemical changes caused by drugs, including their therapeutic and toxic effects. Drugs can stimulate or depress functions and may have agonistic, antagonistic, or other complex effects.
4. Several signaling pathways are involved in how receptors
G-protein coupled receptors (GPCRs) are the largest family of membrane receptors that are linked to intracellular effector proteins via G-protein activation. There are several classes of GPCRs classified based on sequence homology. All GPCRs have seven transmembrane domains and signal through heterotrimeric G proteins. When a ligand binds a GPCR, it activates an associated G protein which then regulates downstream effectors like adenylyl cyclase or phospholipase C. These pathways mediate many physiological processes such as vision, smell, immune response, and neuronal signaling.
This document summarizes the activities and achievements of Nangarhar University in Afghanistan over the past 50 years since its establishment in 1963. It discusses how the Strengthening Higher Education Program (SHEP) has partnered with the university since 2005 to support capacity development of staff, construction of new buildings and facilities, curriculum development, laboratory equipment, and student services. Some challenges mentioned include lengthy bureaucratic procedures and limited university autonomy. Overall, SHEP has helped improve the quality of education and working conditions at Nangarhar University.
This document provides an overview of science and technology in Afghanistan. It discusses Afghanistan's basic statistics such as population size, literacy rates, and education enrollment. It then describes the historical development of S&T institutions in Afghanistan such as universities and research institutes. It notes that decades of war severely damaged S&T infrastructure and depleted human resources. Currently, the government is working to rebuild by expanding education, establishing new universities and technical institutes, and conducting research. However, Afghanistan still faces challenges like weak coordination between S&T institutions and a lack of technical staff. The document outlines future directions such as dedicating funding to S&T and establishing international partnerships to continue developing Afghanistan's S&T capabilities.
CASCADE is a European Union funded project to promote international cooperation. Nangarhar University is Afghanistan's second largest university with over 12,000 students and 500 academic staff. Decades of conflict devastated Afghanistan's infrastructure, agriculture, and education. Key social challenges include a weak health system, food insecurity, lack of irrigation and sustainable agriculture, overexploitation of natural resources, insecure energy access, and threats to security from conflict, drugs, and terrorism.
This document summarizes a training that Mohammad Bayer Darmel received and outlines a proposed animal source food quality assessment lab project for the Veterinary faculty of Ningarhar University. The training covered the application of technology, safety, hygiene, and traceability in food production. It also provided practical experience. The proposed lab project aims to enhance food safety and quality in the region by providing testing facilities and training students, technicians, and researchers. The lab would assess attributes like microbiological quality, protein content, and nitrite levels in meat. If established, it would support workers in the animal health and food quality sectors through increased knowledge and skills.
First Report on Hygiene and Quality Management for Animal Source Foods Afg t...Bayer Darmel
This interim report provides an overview of hygiene and quality management issues for animal source foods in Afghanistan. It discusses how the agricultural sector was impacted by decades of war and how demand for meat and dairy is now increasing. However, local animal products have worse hygiene and safety conditions compared to imported alternatives. Key current problems include a lack of knowledge about hygiene among producers, cross-contamination in retail, no processing facilities, high zoonotic disease risks, and a lack of production and market policies regarding hygiene and quality management. The applicant's interests related to this training program include food safety, quality assurance, hygiene of animal products, and food analysis.
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptxRASHMI M G
Abnormal or anomalous secondary growth in plants. It defines secondary growth as an increase in plant girth due to vascular cambium or cork cambium. Anomalous secondary growth does not follow the normal pattern of a single vascular cambium producing xylem internally and phloem externally.
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptxMAGOTI ERNEST
Although Artemia has been known to man for centuries, its use as a food for the culture of larval organisms apparently began only in the 1930s, when several investigators found that it made an excellent food for newly hatched fish larvae (Litvinenko et al., 2023). As aquaculture developed in the 1960s and ‘70s, the use of Artemia also became more widespread, due both to its convenience and to its nutritional value for larval organisms (Arenas-Pardo et al., 2024). The fact that Artemia dormant cysts can be stored for long periods in cans, and then used as an off-the-shelf food requiring only 24 h of incubation makes them the most convenient, least labor-intensive, live food available for aquaculture (Sorgeloos & Roubach, 2021). The nutritional value of Artemia, especially for marine organisms, is not constant, but varies both geographically and temporally. During the last decade, however, both the causes of Artemia nutritional variability and methods to improve poorquality Artemia have been identified (Loufi et al., 2024).
Brine shrimp (Artemia spp.) are used in marine aquaculture worldwide. Annually, more than 2,000 metric tons of dry cysts are used for cultivation of fish, crustacean, and shellfish larva. Brine shrimp are important to aquaculture because newly hatched brine shrimp nauplii (larvae) provide a food source for many fish fry (Mozanzadeh et al., 2021). Culture and harvesting of brine shrimp eggs represents another aspect of the aquaculture industry. Nauplii and metanauplii of Artemia, commonly known as brine shrimp, play a crucial role in aquaculture due to their nutritional value and suitability as live feed for many aquatic species, particularly in larval stages (Sorgeloos & Roubach, 2021).
The binding of cosmological structures by massless topological defectsSérgio Sacani
Assuming spherical symmetry and weak field, it is shown that if one solves the Poisson equation or the Einstein field
equations sourced by a topological defect, i.e. a singularity of a very specific form, the result is a localized gravitational
field capable of driving flat rotation (i.e. Keplerian circular orbits at a constant speed for all radii) of test masses on a thin
spherical shell without any underlying mass. Moreover, a large-scale structure which exploits this solution by assembling
concentrically a number of such topological defects can establish a flat stellar or galactic rotation curve, and can also deflect
light in the same manner as an equipotential (isothermal) sphere. Thus, the need for dark matter or modified gravity theory is
mitigated, at least in part.
ESR spectroscopy in liquid food and beverages.pptxPRIYANKA PATEL
With increasing population, people need to rely on packaged food stuffs. Packaging of food materials requires the preservation of food. There are various methods for the treatment of food to preserve them and irradiation treatment of food is one of them. It is the most common and the most harmless method for the food preservation as it does not alter the necessary micronutrients of food materials. Although irradiated food doesn’t cause any harm to the human health but still the quality assessment of food is required to provide consumers with necessary information about the food. ESR spectroscopy is the most sophisticated way to investigate the quality of the food and the free radicals induced during the processing of the food. ESR spin trapping technique is useful for the detection of highly unstable radicals in the food. The antioxidant capability of liquid food and beverages in mainly performed by spin trapping technique.
Current Ms word generated power point presentation covers major details about the micronuclei test. It's significance and assays to conduct it. It is used to detect the micronuclei formation inside the cells of nearly every multicellular organism. It's formation takes place during chromosomal sepration at metaphase.
BREEDING METHODS FOR DISEASE RESISTANCE.pptxRASHMI M G
Plant breeding for disease resistance is a strategy to reduce crop losses caused by disease. Plants have an innate immune system that allows them to recognize pathogens and provide resistance. However, breeding for long-lasting resistance often involves combining multiple resistance genes
1. Signal Sorting by G Protein
Linked Receptors
Major advisor:
Dr Jayakumar
Professor and Head
Dept of Vet Pharmacology & Toxicology
Speaker:
M.D Bayer Darmel
Sr MVSc Dept Pharmacology & Toxicology
receptor
tsqi
G protein
cAMPCa2+
intracellular
messenger
enzymechannel
effector
2. History
• Refers to a “receptive substance” describing the cellular
sites of interaction of drugs curare/nicotine and
atropine/pilocarpine in neuromuscularjunctions. (Langley. 1909)
• 1969: proposition of an intermediate transducer to link
distinct receptors to common effector adenylyl effector,
cyclase, and identification of the heterotrimeric G‐
protein,Gs.(John C. Foreman,.2003)
• 1983: rhodopsin was the first GPCR to be cloned
• The classical G protein signaling pathway that was identified very
early on was the activation of the adenylyl cyclase‐cAMP pathway
by G s (Gilman, 1987).
• Rodbell and Gilman were jointly awarded the Nobel Prize in 1994.
(John C. Foreman,.2003)
• 2000: first crystal structure of a GPCR(John C. Foreman,.2003)
3. Noble Prize for G PCR
Rodbell and Gilman were jointly awarded the Nobel Prize in 1994
for their discovery of G protein couple receptors and the role of these
protein in signal transduction in cell
Martin Rodbell, 1925–1998 USA
Alfred Goodman Gilman USA
4. G protein couple receptors
• G protein-coupled receptors (GPCRs),
also known as seven transmembrane
domain receptors, 7TM receptors,
heptahelical receptors, and G protein-
linked receptors (GPLR) .(David L et al,.2005)
• Also called metabotropic receptors and
serpentine receptors.(Miligan.1995 )
5. Importance
G protein-coupled receptors are involved in many diseases,
and are also the target of around half of all modern medicinal
drugs.(Hardman et al,.2001)(Marchese et al.)
G protein-coupled receptors are found only in eukaryotes,
including yeast(Saccharomyces cerevisiae)Saccharomyces cerevisiae), plants,
choanoflagellates, and animals
Pathways involving these receptors are the targets of
hundreds of drugs, including antihistamines,
neuroleptics, antidepressants, and
antihypertensives(.(Miligan.1995 Ad.Ph V32)
• All GPCRs signal via the use of G-proteins
6. GPCRs are receptors for:
• Light, odours and gustative molecules
• Biogenic amines; dopamine, histamine, serotonin
• Eicosanoids .
• opioids,
• amino acids such as GABA, and many other
peptide and protein ligands
• Peptide and protein hormones
Panacreatic hormones
Gastrointestinal
Thyroid (Hardman,.2001)
8. Classification(II)
• Class A (or 1) (Rhodopsin-like)
• Class B (or 2) (Secretin receptor family)
• Class C (or 3) (Metabotropic
glutamate/pheromone)
• Class D (or 4) (Fungal mating pheromone
receptors)
• Class E (or 5) (Cyclic AMP receptors)
• Class F (or 6) (John C. 2000
12. Physiological roles
The visual sense, sense of smell and pheromones (vomeronasal receptors),
Behavioral and mood regulation: receptors in the mammalian brain
( serotonin, dopamine)
Regulation of immune system activity and inflammation (chemokines)
Autonomic nervous system transmission: both the sympathetic and
parasympathetic nervous systems (blood pressure, heart rate and digestive
processes)
The G-Protein-Coupled Receptor GCR1 Regulates DNA
Synthesis
GPCRs comprise the largest family of cell surface receptors. In mice, there are 1000
different receptors involved in smell alone
GPCR are able to regulate the rate of second messenger production or degration
GPLR regulate ion flux through a battery oion chenall by direct GP regulation or via second
messenger.
• The human genome encodes morethan 1,000 members of this
family of receptors, specialized for transducing messages as
diverse as light, smells, tastes, and hormones (.(David L et
alt,.2005)
13. Ligand
• It is a signal triggering molecule binding to a site on a target
protein, by intermolecular forces such as ionic bonds,
hydrogen bonds and Van der Waals forces.
• Ligand can be selective for receptor or non selective .
• Ligands include substrates, inhibitors, activators, and
neurotransmitters.
• The affinity of ligand belongs to intermolecular force
• Can work as agonist or antagonist.(Miligan,1995)
15. Cell-to-cell communication by extracellular
signaling usually involves six steps
• (1) synthesis of the signaling molecule by the signaling cell
• (2) release of the signaling molecule by the signaling cell
• (3) transport of the signal to the target cell
• (4) detection of the signal by a specific receptor protein –
receptor-ligand specificity
• (5) a change in cellular metabolism, function, or development
= cellular respons.
• (6) removal of the signal, which usually terminates the
cellular response – degredation of ligand
16.
17. Structure of GPCR
• Order of segments are
known
– N-terminus..
– Helix
– Intracellular loop
– Extracellular loop
– C-Terminus
19. GPCR cellular domains
• Extracellular domain
• By definition, a receptor's main function is to
recognize and respond to a specific ligand, for
example, a neurotransmitter or hormone
• Transmembrane domain
• Intracellular domain
• Adenylate Cyclase (AC) is a
transmembrane protein, with
cytosolic domains forming the
catalytic site.
20. Coupling to G protein
• Intracellular loop I3
– Main point of interaction
– 12 amino acids near N terminal of I3 mediates specificity (G protein subtype)
– Amino acids near C terminal of I3 mediate efficiency
– Varies in size between receptor subtypes
• Intracellular loop I2 (from TM3 to TM4)
• Mediates specificity and efficacy
• C terminal tail
– Determines efficiency
• Neurotransmitter interacting with amino acids in TM5 and TM6 transmit
conformation change to area of I3
21. G proteins(molecular switches)
• short for guanine nucleotide-binding proteins,
• G-proteins are heterotrimeric proteins composed of α (45 KDa), β (37
KDa), and γ (9 KDa) subunits (David L et alt,.2005)
• G-proteins interact with a receptor comprised of 7-membrane spanning
α-helices. Ligand binding induces. (Michael ,.2005)
Alpha
• Binds to guanosine nucleotides: GDP or GT
• four main families exist for Gα
subunits: Gαs
, Gαi
, Gαq/11
, and Gα12/13
.
(modified by attachment of fatty acid chain)
• Gαs
stimulates the production of cAMP from ATP.
• Gαi
inhibits the production of cAMP from ATP
• Gαq/11
stimulates membrane-bound phospholipase C beta, which
then cleaves PIP2
• Gα12/13
are involved in Rho family GTPase signaling
22. G Proteins
Beta and Gamma(CAAX)
• Five members of Beta subunit are identified(B1-B5)
• Binds to alpha subunit
• Stabilizes G protein in membrane
• Blocks alpha from interacting with effector
• Can be effectors
• The α and γ subunits have covalently attached lipid anchors, that
insert into the plasma membrane, binding a G-protein to the
cytosolic surface of the plasma membrane
• There is a larger family of small GTP-binding switch proteins,
• initiation & elongation factors (protein synthesis)
• Ras (growth factor signal cascades)
• Rab (membrane vesicle targeting and fusion)
• ARF (formation of vesicle coatomer coats)
• Ran (transport of proteins into & out of the nucleus)
• Rho (regulation of actin cytoskeleton
27. G-protein activation
1. Initially the G-protein α subunit has bound GDP, and
the α, β, & γ subunits are complexed together. Gβ,γ
,
the complex of β & γ subunits, inhibits Gα
2. When the ligand binds to the GPCR it Altering the
conformation of the alpha subunit allows it to
exchange GDP for GTP.
3. Substitution of GTP for GDP causes another
conformational change in Gα
.
Gα
-GTP dissociates from the inhibitory βγ subunit
complex, and can now bind to and activate
Adenylate Cyclase
4. Adenylate Cyclase, activated by the stimulatory Gα
-
GTP, catalyzes synthesis of cAMP
5. Protein Kinase A (cAMP-Dependent Protein
Kinase) catalyzes transfer of phosphate from
ATP to serine or threonine residues of various
cellular proteins, altering their activity.
6. The complex of Gβ,γ
that is released when Gα
binds GTP is itself an effector that binds to
and activates or inhibits several other
proteins. For example, Gβ,γ
inhibits one of
several isoforms of Adenylate Cyclase,
contributing to rapid signal turnoff in cells that
Gprotn.gif
28. G protein Inactivation
1. Gα
hydrolyzes GTP to GDP + Pi
(GTPase). The
presence of GDP on Gα
causes it to rebind to the
inhibitory βγ complex. AdenylateCyclase is no
longer activated.
2. Phosphodiesterases catalyze hydrolysis of
cAMP to AMP.
3. Receptor desensitization varies with the
hormone.
In some cases the activated receptor is
phosphorylated via a G-protein Receptor
Kinase.
The phosphorylated receptor then may bind
to a protein β-arrestin
**GTPase activating proteins (GAPs), when
bound to the alpha subunit, enhance the
GTPase activity tremendously. GAPs are
critical negative regulators of G proteins.
30. There are three basic types of secondary
messenger molecules:
• Hydrophobic molecules: like diacylglycerol, IP3
,
and phosphatidylinositols, which are membrane-
associated and diffuse from the plasma membrane
into the space where they can reach and regulate
membrane-associated effector proteins
• Hydrophilic molecules: like cAMP, cGMP, and
Ca2+
, that are located within the cytosol
• Gases: nitric oxide (NO) and carbon monoxide
(CO), which can diffuse both through cytosol and
across cellular membranes.
32. Production of cAMP
1. Adenylyl cyclase produces cAMP by removing
two phosphate groups from ATP.
2. The phosphates are removed as pyrophosphate
(P-P).
3. Along with the removal of pyrophosphate the
molecule is cyclized.
4. cAMP phosphodiesterase then hydrolyzes
cAMP to AMP.
Cholera toxin: inactivates the GTPase activity of
the Gs alpha subunit, thereby keeping it active. This
causes oversecretion of chloride ions and water into
the gut (severe diahrrhea).
Pertussis toxin: this toxin inactivates the alpha
subunit of Gi. This blocks its ability to
negatively regulate its targets (whooping
cough).
34. Rapid and Slow responses to PKA
activation
**Some of the effects of PKA activation are rapid.
Example: the stimulation of glycogen breakdown to
glucose in muscle cells. This occurs by the direct
phosphorylation of proteins involved in glycogen
metabolism. This provides glucose for energy
production in muscle cells within seconds.
**Some of the effects of PKA are slower. Example: the
activation of gene expression, such as the
somatostatin hormone.
• Activated PKA can translocate into the nucleus.
• There it phosphorylates the transcription factor CREB
(cAMP response element binding protein).
3. When CREB is phosphorylated it binds to the cAMP
response element (CRE).
4. CREB-binding protein (CBP) binds to phosphorylated
CREB and activates transcription of genes that contain
CRE sequences, such as the somatostatin gene.
5. Many cAMP-induced genes contain CRE sequences
and are regulated by CREB and CBP.
35. Production of inositol phospholipids
**Phosphatylinositol (PI) 4-phosphate and PI 4,5 bisphosphate are produced by the sequential
actions of PI kinase and PIP kinase, respectively.
**PIs exist in the inner leaflet of the plasma membrane.
**PI 4,5 bisphosphate is especially important because its breakdown produces two different
second messengers.
**PI 4,5 bisphosphate is the least abundant of the PIs, and accounts for only 1% of total
phospholipids.
(Joyce J. Diwan.. 2008)
36. Phospholipase C-β is critical for
GPCR signaling
1. The G protein q (Gq) alpha subunit activates
the enzyme phospholipase C-β (PLC-β) in a
manner similar to how Gs activates adenylyl
cyclase.
2. Activated PLC-β cleaves PI 4,5 bisphosphate
to produce diacylglycerol (DAG) and inositol
1,4,5-trisphosphate (IP3).
3. Importantly, both DAG and IP3 are second
messengers that activate distinct intracellular
signaling molecules.
4. IP3 is a small, water-soluble molecule that
readily diffuses through the cytosol.
5. DAG remains embedded in the plasma
membrane, but like other PM lipids, can
diffuse laterally through the membrane.
37. The targets of IP3 and DAG
IP3: When IP3 diffuses to the membrane of the ER it binds to IP3-gated calcium release
channels (IP3Rs) in the membrane, triggering their opening.
**IP3Rs release calcium from the ER into the cytosol, rapidly increasing the concentration of
calcium in the cytosol. Ca2+
is perhaps the most common second messenger in cells.
**Calcium levels are quickly reduced by channels that pump it out of the cell, and by the
inactivation of IP3 by dephosphorylation and other means.
DAG: DAG has two signaling functions. First, it can be further cleaved to arachidonic acid,
which can initiate a complex cascade of lipid messengers. Second, DAG can activate a
serine/threonine kinase called protein kinase C (PKC).
**PKC requires both Ca2+
and DAG, along with membrane phospholipids, to be activated.
**PKC has numerous protein substrates that are unique from PKA.
38. Calmodulin
1. Calmodulin is a Ca2+
binding protein that has 4 high affinity binding sites for Ca2+
.
2. Calmodulin is extremely abundant in cells and accounts for as much as 1% of total protein.
3. Binding of calcium causes a conformational change in calmodulin.
4. At least two or more Ca2+
must bind before calmodulin changes conformations, making it
behave like a switch to increasing concentrations of calcium.
5. Calmodulin has no enzymatic function, and instead binds to target proteins and alters their
confirmation (as well as its own).
6. One of the most important group of calmodulin targets is the Ca2+
/calmodulin-dependent
protein kinases (CaM-kinases).
39. CaM-kinase II
1. CaM-kinase II is composed of a large
complex of about 12 subunits of CaM-
kinase II. For simplicity, only one is
shown here.
2. Upon Ca2+
/calmodulin binding, CaMKII
changes conformation and is activated.
3. Upon activation, CaMKII
autophosphorylates itself on an
autoinhibitory domain. This
phosphorylation event sustains CaMKII
activity without Ca2+
/calmodulin being
present in two ways. First, it locks
Ca2+
/calmodulin binding to it such that it
will not dissociate without the prolonged
return to normal calcium levels. Second,
it converts the enzyme to a calcium
independent form.
4. After this occurs, CaMKII can only be
inactivated if all of the subunits are
dephosphorylated by phosphatases
(overriding the CaMKII kinase activity).
40. GPCR desensitization
**Cells desensitize, or adapt, when exposed to high levels of ligand for a long period of time.
There are 3 mechanisms of desensitization at the level of the GPCR:
1. Receptor inactivation: The GPCR becomes modified such that it can no longer interact
with its G protein.
2. Receptor sequestration: The GPCR can be internalized and transported to an interior
compartment of the cell such that it no longer is exposed to ligand.
3. Receptor downregulation: The receptor can be degraded by lysosomes after it is
internalized.
G-protein-linked receptor kinases (GRKs): phosphorylate GPCRs upon their activation on
multiple serines and threonines.
This phosphorylation leads to binding of arrestin to the active GPCR. Arrestin triggers
desensitization by 1). inhibiting the binding of the G protein to the GPCR and 2). by
acting as an adaptor protein for the internalization of the receptor. Whether the receptor
is sequestered or degraded depends upon may factors.
41. Conclusion
■ A large family of plasma membrane receptors
with seven transmembrane segments act
through heterotrimeric G proteins. On ligand
binding, these receptors catalyze the exchange
of GTP for GDP bound to an associated G
protein, forcing dissociation of the subunit of
the G protein. This subunit stimulates or
inhibits the activity of a nearby membrane-bound
enzyme, changing the level of its second
messenger product.
42. Contin..
■
The cAMP produced by adenylyl cyclase is an
intracellular second messenger that stimulates
cAMP-dependent protein kinase,which mediates
43. Cont..
■ The cascade of events in which a single molecule
of hormone activates a catalyst that in turn
activates another catalyst, and so on,results in
large signal amplification; this is characteristic of
most hormone activated systems.
• Some receptors stimulate adenylyl cyclase
through Gs; others inhibit it through Gi. Thus
cellular [cAMP] reflects the integrated input of
two (or more) signals
44. Cont..
■ Cyclic AMP is eventually eliminated by cAMP
phosphodiesterase, and Gs turns itself off by
hydrolysis of its bound GTP to GDP.
When the epinephrine signal persists,
-adrenergic
receptor–specific protein kinase and arrestin 2
temporarily desensitize the receptor and cause it
to move into intracellular vesicles.
In some cases, arrestin also acts as a scaffold
protein, bringing together protein components of
a
signaling pathway such as the MAPK cascade
45. Cont..
■ Some serpentine receptors are coupled to a
plasma membrane phospholipase C that cleaves
PIP2 to diacylglycerol and IP3.
By opening Ca2 channels in the endoplasmic
reticulum, IP3 raises cytosolic [Ca2].
Diacylglycerol and Ca2 act together to activate
protein kinase C, which phosphorylates and
changes the activity of specific cellular proteins.
Cellular [Ca2] also regulates a number of other
enzymes, often through calmodulin.
T H E E N DT H E E N D